7Baggers
 Published on: 2025-11-12 19:59:13  newser.com Thu, 13 Nov 2025 01:59:13 GMT
 urogen pharma hits new 52-week high of $23.89, up 81.99%  Markets Mojo Wed, 12 Nov 2025 14:17:53 GMT
 UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch  Investing.com Nigeria Tue, 11 Nov 2025 22:26:27 GMT
 urogen pharma hits new 52-week high of $23.89, up 81.99%  Markets Mojo Mon, 10 Nov 2025 21:27:38 GMT
 urogen pharma hits new 52-week high of $23.64, up 84.34%  Markets Mojo Sun, 09 Nov 2025 13:49:56 GMT
 (urgn) movement within algorithmic entry frameworks  news.stocktradersdaily.com Sun, 09 Nov 2025 09:56:02 GMT
 urogen pharma ltd. (nasdaq:urgn) q3 2025 earnings call transcript  Insider Monkey Sun, 09 Nov 2025 05:59:49 GMT
 urogen pharma hits day high with 18.83% surge in stock price  Markets Mojo Sat, 08 Nov 2025 02:04:45 GMT
 urogen pharma’s earnings call: growth amid challenges  TipRanks Sat, 08 Nov 2025 01:12:01 GMT
 Urogen Pharma stock hits 52-week high at 23.66 USD  Investing.com Fri, 07 Nov 2025 20:02:09 GMT
 UroGen Pharma Joins Rank Of Stocks With RS Ratings Over 90  Investor's Business Daily Fri, 07 Nov 2025 08:00:00 GMT
 UroGen Pharma’s Earnings Call: Growth Amid Challenges  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 urogen reports 77.8% response rate in bladder cancer drug trial by investing.com  Investing.com Nigeria Fri, 07 Nov 2025 07:53:57 GMT
 urogen pharma’s zusduri launch drives q3 growth  TipRanks Fri, 07 Nov 2025 05:55:45 GMT
 Decoding UroGen Pharma Ltd (URGN): A Strategic SWOT Insight  GuruFocus Fri, 07 Nov 2025 05:41:06 GMT
 urogen pharma (urgn) reports q3 loss, misses revenue estimates  sharewise.com Fri, 07 Nov 2025 05:01:28 GMT
 UroGen Pharma (URGN) Sees Strong Demand for ZUSDURI  GuruFocus Fri, 07 Nov 2025 04:02:30 GMT
 urogen pharma q3 2025 earnings call transcript  MarketBeat Fri, 07 Nov 2025 03:53:17 GMT
 urogen pharma stock price target raised to $30 from $25 at d. boral capital  Investing.com Canada Fri, 07 Nov 2025 02:22:46 GMT
 earnings call transcript: urogen pharma q3 2025 sees revenue miss, stock dips  Investing.com Nigeria Fri, 07 Nov 2025 01:23:15 GMT
 UroGen Pharma Misses Revenue Targets But Analysts Stay Upbeat  Finimize Thu, 06 Nov 2025 21:48:17 GMT
 published on: 2025-11-06 12:46:02  newser.com Thu, 06 Nov 2025 18:46:02 GMT
 urogen pharma stock jumps after positive phase 3 trial results by investing.com  Investing.com Australia Thu, 06 Nov 2025 16:47:48 GMT
 urogen (urgn) q3 2025 earnings call transcript  The Motley Fool Thu, 06 Nov 2025 16:03:00 GMT
 UroGen Pharma (URGN) Reports Promising Results from Phase 3 UTOP  GuruFocus Thu, 06 Nov 2025 13:54:36 GMT
 UroGen Pharma earnings missed, revenue fell short of estimates  Investing.com Thu, 06 Nov 2025 13:51:36 GMT
 urogen (urgn) reports q3 revenue miss; focuses on zusduri's grow  GuruFocus Thu, 06 Nov 2025 13:50:33 GMT
 urogen pharma's q3 revenue misses estimates  MarketScreener Thu, 06 Nov 2025 13:37:41 GMT
 urogen reports 77.8% response rate in bladder cancer drug trial  Investing.com Thu, 06 Nov 2025 13:11:10 GMT
 UroGen Pharma Ltd. SEC 10-Q Report  TradingView Thu, 06 Nov 2025 13:03:00 GMT
 UroGen Pharma Q3 2025 Earnings Preview  MSN Thu, 06 Nov 2025 08:17:21 GMT
 Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 UroGen Pharma’s ZUSDURI Launch Drives Q3 Growth  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 UroGen Pharma Ltd. Q3 2025 Financial Results  TradingView Thu, 06 Nov 2025 08:00:00 GMT
 urogen pharma q3 2025 earnings preview  MSN Wed, 05 Nov 2025 18:37:14 GMT

UroGen Pharma Ltd
(NASDAQ:URGN) 

URGN stock logo

UroGen Pharma Ltd., a biopharmaceutical company, engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmy...

Founded: 2004
Full Time Employees: 187
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends